Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Gross Margin (2020 - 2025)

Historic Gross Margin for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to 79.85%.

  • RxSight's Gross Margin rose 84400.0% to 79.85% in Q3 2025 from the same period last year, while for Sep 2025 it was 74.98%, marking a year-over-year increase of 65300.0%. This contributed to the annual value of 70.71% for FY2024, which is 103500.0% up from last year.
  • Latest data reveals that RxSight reported Gross Margin of 79.85% as of Q3 2025, which was up 84400.0% from 74.89% recorded in Q2 2025.
  • Over the past 5 years, RxSight's Gross Margin peaked at 79.85% during Q3 2025, and registered a low of 16.58% during Q2 2021.
  • Its 5-year average for Gross Margin is 52.54%, with a median of 59.27% in 2023.
  • In the last 5 years, RxSight's Gross Margin soared by 9400bps in 2021 and then surged by 587300bps in 2022.
  • Over the past 5 years, RxSight's Gross Margin (Quarter) stood at 34.05% in 2021, then skyrocketed by 35bps to 46.13% in 2022, then soared by 34bps to 61.77% in 2023, then grew by 16bps to 71.59% in 2024, then increased by 12bps to 79.85% in 2025.
  • Its last three reported values are 79.85% in Q3 2025, 74.89% for Q2 2025, and 74.76% during Q1 2025.